Phase I, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Minnelide™ Capsules Given Alone or in Combination With Protein-Bound Paclitaxel in Patients With Advanced Solid Tumors
The purpose of this phase I study is to evaluate the safety and efficacy of Minnelide alone or in combination with protein-bound paclitaxel among patients with advanced solid tumors, including pancreatic cancer.
Study ID: Minnelide 101
Trial Phase: Phase I
Trial Sponsor: Minneamrita Therapeutics, LLC
Therapies Used in This Trial: Nab-paclitaxel, Minnelide™